Literature DB >> 8004045

Electron microscopy and the polymerase chain reaction of spirochetes from the blood of patients with Lyme disease.

D Hulínská1, M Krausová, D Janovská, H Rohácová, J Hancil, H Mailer.   

Abstract

Results of studies using direct antigen detection suggest that seronegative Lyme borreliosis is not rare and support the hypothesis that Borrelia antigens can persist in humans. We report three successful cultures from blood out of 30 attempts from 96 Lyme disease patients. The proof of borreliaemia in early or late phases of Lyme disease by immuno-capture electron microscopy has practical importance for subsequent cultivation. The polymerase chain reaction with oligonucleotide sequences directed against 16S rRNA identified two of our blood isolates as Borrelia burgdorferi genospecies III., VS 461 group, and one as Borrelia garinii sp. nov. All of the three isolates were reactive with monoclonal antibody H9724 against flagellin and with antibody against main extracellular protein at 83 kDa. Borrelia garinii had a single predominant protein OspA at 33.5 kDa and reacted with monoclonal antibody H5332 in contrast to two isolates of the VS 461 group with two major proteins OspA and OspB at 32.5 and 35 kDa. We conclude that isolation of spirochetes from the blood might prove successful in clinically selected cases of Lyme borreliosis. Immuno-capture electron microscopy has proved to be a sensitive assay for monitoring and studying Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8004045

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  4 in total

1.  A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated.

Authors:  S E Phillips; L H Mattman; D Hulínská; H Moayad
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

2.  Long-term results in patients with Lyme arthritis following treatment with ceftriaxone.

Authors:  H Valesová; J Mailer; J Havlík; D Hulínská; J Hercogová
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

3.  Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review.

Authors:  Z Hubálek; J Halouzka
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

4.  Ceftriaxone in the treatment of Lyme neuroborreliosis.

Authors:  H Rohácová; J Hancil; D Hulinská; H Mailer; J Havlík
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.